These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10820893)

  • 61. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
    Winkler UH; Hölscher T; Schulte H; Zierleyn JP; Collet W; Schindler AE
    Gynecol Endocrinol; 1996 Aug; 10(4):265-71. PubMed ID: 8908527
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cardiovascular risks associated with low-dose combined oral contraceptives].
    Merki-Feld GS
    Ther Umsch; 2001 Sep; 58(9):564-9. PubMed ID: 11594156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
    Contracept Technol Update; 1997 Dec; 18(12):145-8. PubMed ID: 12348219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Schwingl PJ; Shelton J
    Contraception; 1997 Mar; 55(3):125-9. PubMed ID: 9114999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The combined oral contraceptive. Risks and adverse effects in perspective.
    Bagshaw S
    Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The public health implications of the 1995 'pill scare'.
    Furedi A
    Hum Reprod Update; 1999; 5(6):621-6. PubMed ID: 10652971
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Another pill scare -- should we audit its impact?
    Bromham DR
    Audit Unit News; 1996 Jan; 1(4):2-3. PubMed ID: 12346948
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined oral contraceptives, smoking, and cardiovascular risk.
    Farley TM; Meirik O; Chang CL; Poulter NR
    J Epidemiol Community Health; 1998 Dec; 52(12):775-85. PubMed ID: 10396518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined oral contraceptives: venous thrombosis.
    de Bastos M; Stegeman BH; Rosendaal FR; Van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010813. PubMed ID: 24590565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined oral contraception and the risk of venous thromboembolism.
    Mills A
    Hum Reprod; 1997 Dec; 12(12):2595-8. PubMed ID: 9455819
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    Weill A; Dalichampt M; Raguideau F; Ricordeau P; Blotière PO; Rudant J; Alla F; Zureik M
    BMJ; 2016 May; 353():i2002. PubMed ID: 27164970
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U; Lambotte R
    Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.